Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

My Take: 4 Strong Growth Stocks to Buy This Week


After a down 2022, growth stocks are making a big comeback this year. The S 500 Growth index is up more than 21% this year, while the S 500 Value index is up just a little more than 13%. Growth stocks have the potential to boost earnings more quickly than typical stocks, which provides a nice hedge for investors against inflation.

Even though Eli Lilly (NYSE: LLY), Vertex Therapeutics (NASDAQ: VRTX), Royal Caribbean Cruises (NYSE: RCL), and Stag Industrial (NYSE: STAG) are already all up 16% or more so far this year, each should benefit from macrotrends that will continue to drive revenue and profits.

Pharmaceutical giant Eli Lilly is experiencing huge growth in sales for its diabetes drugs, especially type-2 diabetes medication Mounjaro (tirzepatide), which is likely to be approved by the U.S. Food and Drug Administration (FDA) as a weight-loss drug. In the first quarter, excluding COVID-19 therapies, revenue was up 10%, thanks mainly to improved sales of diabetes therapies Mounjaro, Trulicity, and Jardiance.

Continue reading


Source Fool.com

Vertex Pharmaceuticals Inc. Aktie

468,45 €
0,11 %
Ein geringer Gewinn bei Vertex Pharmaceuticals Inc. heute, um 0,11 %.
Vertex Pharmaceuticals Inc. ist ein klarer Community-Favorit mit mehr Buy- als Sell-Einschätzungen.
Trotz eines Kursziels von 450 €, das unter 468.45 € liegt, ergibt sich für Vertex Pharmaceuticals Inc. ein negatives Potenzial von -3.94%.
Like: 0
LLY
Teilen

Kommentare